Moltkiopsis ciliata
Moltkiopsis ciliata · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Moltkiopsis ciliata is a botanical specimen recognized for its unique medicinal properties within traditional healing practices. Researchers have focused specifically on the potential of this plant to combat systemic infections such as septicemia. Through various specialized preparations, scientists are able to isolate the most potent bioactive compounds from its tissues. These concentrated extracts serve as the primary medium for studying the plant's therapeutic efficacy against bloodstream pathogens. Understanding the chemical profile of these extracts is essential for developing new treatments for life-threatening inflammatory conditions.
- Synonyms
- Lithospermum Ciliatum · Moltkia Ciliata · 4 more
- Common names
- Not available
- Family
- Boraginaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Moltkiopsis ciliata is a unique botanical species known by various regional names across the globe. In English-speaking regions, it is frequently referred to by its common name, the Callous-leaved Gromwell. This plant also carries the designation Мольткиопсис реснитчатый within Russian-speaking communities. In Hebrew, enthusiasts and botanists identify the species as גלעינון החוף. These diverse naming conventions highlight the wide geographic distribution and linguistic variety associated with this plant.
Sources: Catalogue of Life (COL)
Synonyms
Moltkiopsis ciliata is a botanical subject characterized by a complex history of taxonomic classification. Throughout various studies, the species has been identified under several different names, including the synonym Lithospermum angustifolium. Its nomenclature further expands to include Lithospermum callosum var. asperrimum and Lithospermum ciliatum. Additionally, researchers have historically referred to this plant as Lithospermum niveum. Finally, the name Margarospermum latifolium serves as another recognized synonym within its diverse botanical record.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Moltkiopsis ciliata is a specialized organism that belongs to the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. This plant is further organized into the order Boraginales, showcasing its specific evolutionary lineage. It also falls under the family Boraginaceae, which provides insight into its botanical characteristics. Finally, its unique identity is defined by its placement within the genus Moltkiopsis.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Boraginales |
| Family | Boraginaceae |
| Genus | Moltkiopsis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Moltkiopsis ciliata is a resilient plant species with a widespread presence across the African continent. Its distribution spans various regions, including the diverse landscapes of Northeast Tropical Africa, specifically within Chad and the Sudan-South Sudan borderlands. In addition to these tropical areas, the species also inhabits parts of Northern Africa. It can be found growing in the unique environments of Algeria, Egypt, and Libya. This broad geographical range highlights the plant's ability to adapt to different climatic conditions throughout Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Moltkiopsis ciliata is characterized by its distinct growth form as a herbaceous plant. This species functions as a self-supporting organism, maintaining its structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Moltkiopsis ciliata serves as one of the desert-adapted medicinal plants investigated for its potential to treat septicemia induced by multidrug-resistant bacteria. This plant was evaluated as part of a study focused on developing alternative combination therapies to combat life-threatening bloodstream infections. Researchers tested its extracts to determine antimicrobial activity, antioxidant properties, and its ability to inhibit COX-1 and COX-2 enzymes. While the study highlighted the superior efficacy of Jasonia candicans, Moltkiopsis ciliata remains a key component in the search for new strategies to manage septic patients. Its inclusion in these therapeutic trials aims to address the critical challenge posed by pathogens that persist despite conventional antibiotic treatment.
Preparations
Moltkiopsis ciliata is prepared as extracts to be investigated as part of a therapeutic approach for treating septicemia. These desert-adapted plant extracts are evaluated for their specific antimicrobial activity against multidrug-resistant bacteria. In this research, the preparation of such extracts serves to explore alternative strategies for managing life-threatening infections. The study specifically assesses how these botanical preparations interact with pathogens through assays like agar diffusion and broth microdilution. Ultimately, the use of Moltkiopsis ciliata in extract form is part of a broader effort to develop combination therapies to combat antibiotic resistance.